- Home
- ASC vs LAB Comparison
ASC vs LAB Comparison
Compare ASC & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASC
- LAB
- Stock Information
- Founded
- ASC 2010
- LAB 1999
- Country
- ASC Bermuda
- LAB United States
- Employees
- ASC N/A
- LAB N/A
- Industry
- ASC Marine Transportation
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- ASC Consumer Discretionary
- LAB Industrials
- Exchange
- ASC Nasdaq
- LAB Nasdaq
- Market Cap
- ASC 524.6M
- LAB 449.9M
- IPO Year
- ASC 2013
- LAB 2011
- Fundamental
- Price
- ASC $12.83
- LAB $1.24
- Analyst Decision
- ASC Buy
- LAB Hold
- Analyst Count
- ASC 3
- LAB 2
- Target Price
- ASC $13.67
- LAB $1.35
- AVG Volume (30 Days)
- ASC 539.9K
- LAB 1.6M
- Earning Date
- ASC 11-05-2025
- LAB 11-04-2025
- Dividend Yield
- ASC 7.42%
- LAB N/A
- EPS Growth
- ASC N/A
- LAB N/A
- EPS
- ASC 0.78
- LAB N/A
- Revenue
- ASC $309,326,000.00
- LAB $169,737,000.00
- Revenue This Year
- ASC N/A
- LAB N/A
- Revenue Next Year
- ASC $20.24
- LAB N/A
- P/E Ratio
- ASC $16.45
- LAB N/A
- Revenue Growth
- ASC N/A
- LAB 79.77
- 52 Week Low
- ASC $8.32
- LAB $0.92
- 52 Week High
- ASC $13.85
- LAB $2.25
- Technical
- Relative Strength Index (RSI)
- ASC 58.67
- LAB 50.02
- Support Level
- ASC $12.46
- LAB $1.07
- Resistance Level
- ASC $13.17
- LAB $1.25
- Average True Range (ATR)
- ASC 0.36
- LAB 0.07
- MACD
- ASC 0.03
- LAB 0.00
- Stochastic Oscillator
- ASC 69.74
- LAB 61.11
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.